Sanofi - Clinical Trials Arena
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here
X

Sanofi reports positive data for rare disease drug olipudase alfa

Sanofi
Sanofi is developing olipudase alfa to treat acid sphingomyelinase deficiency. Credit: Lionel Allorge.